PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
LAS VEGAS–(BUSINESS WIRE)–PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, PharmaCyte had approximately $15.5 million in cash and also…